Relationship of DNA adducts derived from 2-acetylaminofluorene to cell proliferation and the induction of rodent liver and bladder tumors

Samuel Monroe Cohen, L. B. Ellwein

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Pharmacokinetic models have been developed to assist in extrapolating results from rodent bioassays. However, in numerous circumstances, it is necessary to combine such models with cellular response models to fully define interspecies and dose extrapolations. Interactions between pharmacokinetic target tissue end points (DNA adduct formation) and cellular proliferation in liver and urinary bladder carcinogenesis is illustrated with the results from the ED01 study involving 2-acetylaminofluorene administered to female mice. The interaction of genotoxic and cell proliferative effects are also illustrated in a co-carcinogenesis study with low doses of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and high doses of sodium saccharin. The application of such interactions to humans is illustrated for the case of cigarette smoke-induced bladder cancer.

Original languageEnglish (US)
Pages (from-to)136-142
Number of pages7
JournalToxicologic Pathology
Volume23
Issue number2
DOIs
StatePublished - Jan 1 1995

Fingerprint

2-Acetylaminofluorene
DNA Adducts
Cell proliferation
Urinary Bladder Neoplasms
Liver
Tumors
Rodentia
Carcinogenesis
Pharmacokinetics
Cell Proliferation
Saccharin
Smoke
Cell Communication
Tobacco Products
Biological Assay
Urinary Bladder
Bioassay
Extrapolation
Tissue
formamide

Keywords

  • Bladder carcinogenesis
  • liver carcinogenesis
  • risk assessment

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Toxicology
  • Cell Biology

Cite this

@article{67a9db4026704f96aabf32b139b135a1,
title = "Relationship of DNA adducts derived from 2-acetylaminofluorene to cell proliferation and the induction of rodent liver and bladder tumors",
abstract = "Pharmacokinetic models have been developed to assist in extrapolating results from rodent bioassays. However, in numerous circumstances, it is necessary to combine such models with cellular response models to fully define interspecies and dose extrapolations. Interactions between pharmacokinetic target tissue end points (DNA adduct formation) and cellular proliferation in liver and urinary bladder carcinogenesis is illustrated with the results from the ED01 study involving 2-acetylaminofluorene administered to female mice. The interaction of genotoxic and cell proliferative effects are also illustrated in a co-carcinogenesis study with low doses of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and high doses of sodium saccharin. The application of such interactions to humans is illustrated for the case of cigarette smoke-induced bladder cancer.",
keywords = "Bladder carcinogenesis, liver carcinogenesis, risk assessment",
author = "Cohen, {Samuel Monroe} and Ellwein, {L. B.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1177/019262339502300206",
language = "English (US)",
volume = "23",
pages = "136--142",
journal = "Toxicologic Pathology",
issn = "0192-6233",
publisher = "SAGE Publications Inc.",
number = "2",

}

TY - JOUR

T1 - Relationship of DNA adducts derived from 2-acetylaminofluorene to cell proliferation and the induction of rodent liver and bladder tumors

AU - Cohen, Samuel Monroe

AU - Ellwein, L. B.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Pharmacokinetic models have been developed to assist in extrapolating results from rodent bioassays. However, in numerous circumstances, it is necessary to combine such models with cellular response models to fully define interspecies and dose extrapolations. Interactions between pharmacokinetic target tissue end points (DNA adduct formation) and cellular proliferation in liver and urinary bladder carcinogenesis is illustrated with the results from the ED01 study involving 2-acetylaminofluorene administered to female mice. The interaction of genotoxic and cell proliferative effects are also illustrated in a co-carcinogenesis study with low doses of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and high doses of sodium saccharin. The application of such interactions to humans is illustrated for the case of cigarette smoke-induced bladder cancer.

AB - Pharmacokinetic models have been developed to assist in extrapolating results from rodent bioassays. However, in numerous circumstances, it is necessary to combine such models with cellular response models to fully define interspecies and dose extrapolations. Interactions between pharmacokinetic target tissue end points (DNA adduct formation) and cellular proliferation in liver and urinary bladder carcinogenesis is illustrated with the results from the ED01 study involving 2-acetylaminofluorene administered to female mice. The interaction of genotoxic and cell proliferative effects are also illustrated in a co-carcinogenesis study with low doses of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and high doses of sodium saccharin. The application of such interactions to humans is illustrated for the case of cigarette smoke-induced bladder cancer.

KW - Bladder carcinogenesis

KW - liver carcinogenesis

KW - risk assessment

UR - http://www.scopus.com/inward/record.url?scp=0029089709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029089709&partnerID=8YFLogxK

U2 - 10.1177/019262339502300206

DO - 10.1177/019262339502300206

M3 - Article

C2 - 7569667

AN - SCOPUS:0029089709

VL - 23

SP - 136

EP - 142

JO - Toxicologic Pathology

JF - Toxicologic Pathology

SN - 0192-6233

IS - 2

ER -